Summary
Knowledge on the physical and biological aspects of Auger-electron emission is described and the major attempts to use such emitters in cancer therapy are discussed. Focus is on the need for nuclear localization of the Auger-electron emitters, i.e. preferably targeting the nuclear DNA, to have a good therapy effect. Delivery of Auger-electron emitters using nucleoside analogues, DNA-intercalators, minor groove binders, hormone receptor ligands and oligonucleotides are described as well as the need for nuclear localization signals in peptides and proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- SSB:
-
Single-strand break (in DNA)
- DSB:
-
Double-strand break (in DNA)
- BrdUR:
-
Bromodeoxyuridine
- IdUR:
-
Iododeoxyuridine
- RBE:
-
Relative biological effectiveness
- ER:
-
Estrogen receptor
- TFO:
-
Triplex-forming ologonucleotides
- DMSO:
-
Dimethyl sulfoxide (radical scavenger)
- Mbp:
-
Mega base pair
- D0 :
-
Cell survival parameter that describes the exponential part of a cell survival curve of type n = no *e−D/D o
- SPECT:
-
Single photon emission computed tomography
- PET:
-
Positron emission tomography
- NLS:
-
Nuclear localizing signal
References
Auger, P. (1925) Sur les rayons b secondaires produits dans un gaz par des rayons X. In Comptes Rendues Hebdomadaires des Seances de l’Academie des Sciences, vol. 180, pp. 65-8.
Humm, J.L., Howell, R.W. and Rao, D.V. (1994) Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys, 21, 1901-15.
Pomplun, E. and Sutmann, G. (2004) Is coulomb explosion a damaging mechanism for (125)IUdR? Int J Radiat Biol, 80, 855-60.
Hofer, K.G. (2000) Biophysical aspects of Auger processes. Acta Oncol, 39, 651-7.
Warters, R.L., Hofer, K.G., Harris, C.R. and Smith, J.M. (1978) Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage. Curr Top Radiat Res Q, 12, 389-407.
Hofer, K.G., Prensky, W. and Hughes, W.L. (1969) Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer Inst, 43, 763-73.
Ertl, H.H., Feinendegen, L.E. and Heiniger, H.J. (1970) Iodine-125, a tracer in cell biology: physical properties and biological aspects. Phys Med Biol, 15, 447-56.
Krisch, R.E. and Ley, R.D. (1974) Induction of lethality and DNA breakage by the decay of iodine-125 in bacteriophage T4. Int J Radiat Biol Relat Stud Phys Chem Med, 25, 21-30.
Painter, R.B., Young, B.R. and Burk, H.J. (1974) Non-repairable strand breaks induced by 125I incorporated into mammalian DNA. Proc Natl Acad Sci USA, 71, 4836-8.
Martin, R.F. and Haseltine, W.A. (1981) Range of radiochemical damage to DNA with decay of iodine-125. Science, 213, 896-8.
Adelstein, S.J. and Kassis, A.I. (1996) Strand breaks in plasmid DNA following positional changes of Auger-electron-emitting radionuclides. Acta Oncol, 35, 797-801.
Kassis, A.I., Harapanhalli, R.S. and Adelstein, S.J. (1999) Comparison of strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125. Radiat Res, 151, 167-76.
Sahu, S.K., Kortylewicz, Z.P., Baranowska-Kortylewicz, J., Taube, R.A., Adelstein, S.J. and Kassis, A.I. (1997) Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA. Radiat Res, 147, 401-8.
Kassis, A.I., Harapanhalli, R.S. and Adelstein, S.J. (1999) Strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125: direct compared to indirect effects. Radiat Res, 152, 530-8.
Bishayee, A., Rao, D.V., Bouchet, L.G., Bolch, W.E. and Howell, R.W. (2000) Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210. Radiat Res, 153, 416-27.
Walicka, M.A., Adelstein, S.J. and Kassis, A.I. (1998) Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks. Radiat Res, 149, 134-41.
Walicka, M.A., Adelstein, S.J. and Kassis, A.I. (1998) Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival. Radiat Res, 149, 142-6.
Elmroth, K. and Stenerlow, B. (2005) DNA-incorporated 125I induces more than one doublestrand break per decay in mammalian cells. Radiat Res, 163, 369-73.
Hofer, K.G., Lin, X. and Schneiderman, M.H. (2000) Paradoxical effects of iodine-125 decays in parent and daughter DNA: a new target model for radiation damage. Radiat Res, 153, 428-35.
Elmroth, K. and Stenerlöw, B. (2007) Influence of chromatin structure on double-strand break induction in mammalian cells irradiated with DNA-incorporated 125-I. Radiat Res, 168, 312-318.
Kassis, A.I. (2004) The amazing world of auger electrons. Int J Radiat Biol, 80, 789-803.
Adelstein, S.J., Kassis, A.I., Bodei, L. and Mariani, G. (2003) Radiotoxicity of iodine-125 and other auger-electron-emitting radionuclides: background to therapy. Cancer Biother Radiopharm, 18, 301-16.
O’Donoghue, J.A. and Wheldon, T.E. (1996) Targeted radiotherapy using Auger electron emitters. Phys Med Biol, 41, 1973-92.
Bloomer, W.D. and Adelstein, S.J. (1975) Letter: antineoplastic effect of iodine-125-labelled iododeoxyuridine. Int J Radiat Biol Relat Stud Phys Chem Med, 27, 509-11.
Bloomer, W.D. and Adelstein, S.J. (1977) 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature, 265, 620-1.
Baranowska-Kortylewicz, J., Makrigiorgos, G.M., Van den Abbeele, A.D., Berman, R.M., Adelstein, S.J. and Kassis, A.I. (1991) 5-[123I]iodo-2′-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys, 21, 1541-51.
Xue, L.Y., Butler, N.J., Makrigiorgos, G.M., Adelstein, S.J. and Kassis, A.I. (2002) Bystander effect produced by radiolabeled tumor cells in vivo. Proc Natl Acad Sci USA, 99, 13765-70.
Kishikawa, H., Wang, K., Adelstein, S.J. and Kassis, A.I. (2006) Inhibitory and stimulatory bystander effects are differentially induced by Iodine-125 and Iodine-123. Radiat Res, 165, 688-94.
Kassis, A.I., Adelstein, S.J., Haydock, C., Sastry, K.S., McElvany, K.D. and Welch, M.J. (1982) Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res, 90, 362-73.
Makrigiorgos, G.M., Kassis, A.I., Baranowska-Kortylewicz, J., McElvany, K.D., Welch, M.J., Sastry, K.S. and Adelstein, S.J. (1989) Radiotoxicity of 5-[123I]iodo-2′-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2′-deoxyuridine. Radiat Res, 118, 532-44.
Bodei, L., Kassis, A.I., Adelstein, S.J. and Mariani, G. (2003) Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications. Cancer Biother Radiopharm, 18, 861-77.
Mairs, R.J., Wideman, C.L., Angerson, W.J., Whateley, T.L., Reza, M.S., Reeves, J.R., Robertson, L.M., Neshasteh-Riz, A., Rampling, R., Owens, J., Allan, D. and Graham, D.I. (2000) Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model. Br J Cancer, 82, 74-80.
Reza, M.S. and Whateley, T.L. (1998) Iodo-2′-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain. J Microencapsul, 15, 789-801.
Martin, R.F. (1977) Induction of double-stranded breaks in DNA by binding with an 125ilabelled acridine. Int J Radiat Biol Relat Stud Phys Chem Med, 32, 491-7.
Kassis, A.I., Fayad, F., Kinsey, B.M., Sastry, K.S. and Adelstein, S.J. (1989) Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells. Radiat Res, 118, 283-94.
Martin, R.F., Bradley, T.R. and Hodgson, G.S. (1979) Cytotoxicity of an 125I-labeled DNAbinding compound that induces double-stranded DNA breaks. Cancer Res, 39, 3244-7.
Areberg, J., Norrgren, K. and Mattsson, S. (1999) Absorbed doses to patients from 191Pt-, 193mPt- and 195mPt-cisplatin. Appl Radiat Isot, 51, 581-6.
Howell, R.W., Kassis, A.I., Adelstein, S.J., Rao, D.V., Wright, H.A., Hamm, R.N., Turner, J.E. and Sastry, K.S. (1994) Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells. Radiat Res, 140, 55-62.
Chaires, J.B., Herrera, J.E. and Waring, M.J. (1990) Preferential binding of daunomycin to 5′ATCG and 5′ATGC sequences revealed by footprinting titration experiments. Biochemistry, 29, 6145-53.
Wang, A.H., Ughetto, G., Quigley, G.J. and Rich, A. (1987) Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution. Biochemistry, 26, 1152-63.
Ickenstein, L.M., Edwards, K., Sjoberg, S., Carlsson, J. and Gedda, L. (2006) A novel 125Ilabeled daunorubicin derivative for radionuclide-based cancer therapy. Nucl Med Biol, 33, 773-83.
Kullberg, E.B., Wei, Q., Capala, J., Giusti, V., Malmstrom, P.U. and Gedda, L. (2005) EGFreceptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation. Int J Radiat Biol, 81, 621-9.
Murray, V. and Martin, R.F. (1988) Sequence specificity of 125I-labelled Hoechst 33258 in intact human cells. J Mol Biol, 201, 437-42.
Lobachevsky, P.N. and Martin, R.F. (2004) Plasmid DNA breakage by decay of DNA-associated auger emitters: experiments with 123I/125I-iodoHoechst 33258. Int J Radiat Biol, 80, 915-20.
Harapanhalli, R.S., McLaughlin, L.W., Howell, R.W., Rao, D.V., Adelstein, S.J. and Kassis, A.I. (1996) [125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistribution. J Med Chem, 39, 4804-9.
Yasui, L.S., Chen, K., Wang, K., Jones, T.P., Caldwell, J., Guse, D. and Kassis, A.I. (2007) Using Hoechst 33342 to target radioactivity to the cell nucleus. Radiat Res, 167, 167-75.
Chen, K., Adelstein, S.J. and Kassis, A.I. (2004) Molecular simulation of ligand-binding with DNA: implications for 125I-labeled pharmaceutical design. Int J Radiat Biol, 80, 921-6.
Bronzert, D.A., Hochberg, R.B. and Lippman, M.E. (1982) Specific cytotoxicity of 16 alpha[125I]iodoestradiol for estrogen receptor-containing breast cancer cells. Endocrinology, 110, 2177-82.
Yasui, L., Hughes, A. and DeSombre, E. (2001) Relative biological effectiveness of accumulated 125IdU and 125I-estrogen decays in estrogen receptor-expressing MCF-7 human breast cancer cells. Radiat Res, 155, 328-34.
DeSombre, E.R., Shafii, B., Hanson, R.N., Kuivanen, P.C. and Hughes, A. (1992) Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Res, 52, 5752-8.
DeSombre, E.R., Harper, P.V., Hughes, A., Mease, R.C., Gatley, S.J., DeJesus, O.T. and Schwartz, J.L. (1988) Bromine-80m radiotoxicity and the potential for estrogen receptordirected therapy with auger electrons. Cancer Res, 48, 5805-9.
Kearney, T., Hughes, A., Hanson, R.N. and DeSombre, E.R. (1999) Radiotoxicity of Auger electron-emitting estrogens in MCF-7 spheroids: a potential treatment for estrogen receptorpositive tumors. Radiat Res, 151, 570-9.
Panyutin, I.G. and Neumann, R.D. (2005) The potential for gene-targeted radiation therapy of cancers. Trends Biotechnol, 23, 492-6.
Sedelnikova, O.A., Luu, A.N., Karamychev, V.N., Panyutin, I.G. and Neumann, R.D. (2001) Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for antigene radiotherapy. Int J Radiat Oncol Biol Phys, 49, 391-6.
Sedelnikova, O.A., Panyutin, I.V., Neumann, R.D., Bonner, W.M. and Panyutin, I.G. (2004) Assessment of DNA damage produced by 125I-triplex-forming oligonucleotides in cells. Int J Radiat Biol, 80, 927-31.
Chen, P., Wang, J., Hope, K., Jin, L., Dick, J., Cameron, R., Brandwein, J., Minden, M. and Reilly, R.M. (2006) Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. J Nucl Med, 47, 827-36.
Ginj, M., Hinni, K., Tschumi, S., Schulz, S. and Maecke, H.R. (2005) Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters. J Nucl Med, 46, 2097-103.
Janson, E.T., Westlin, J.E., Ohrvall, U., Oberg, K. and Lukinius, A. (2000) Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors. J Nucl Med, 41, 1514-8.
Reilly, R.M., Kiarash, R., Cameron, R.G., Porlier, N., Sandhu, J., Hill, R.P., Vallis, K., Hendler, A. and Gariepy, J. (2000) 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med, 41, 429-38.
Stepanek, J., Ilvonen, S.A., Kuronen, A.A., Lampinen, J.S., Savolainen, S.E. and Valimaki, P.J. (2000) Radiation spectra of 111In, 113mIn and 114mIn. Acta Oncol, 39, 667-71.
Stepanek, J., Larsson, B. and Weinreich, R. (1996) Auger-electron spectra of radionuclides for therapy and diagnostics. Acta Oncol, 35, 863-8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Lundqvist, H., Stenerlöw, B., Gedda, L. (2008). The Auger Effect in Molecular Targeting Therapy. In: Stigbrand, T., Carlsson, J., Adams, G.P. (eds) Targeted Radionuclide Tumor Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8696-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8696-0_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8695-3
Online ISBN: 978-1-4020-8696-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)